Frequency Total Stockholder Equity from 2010 to 2024
| KRRO Stock | 54.99 1.74 3.27% |
Total Stockholder Equity | First Reported 2010-12-31 | Previous Quarter 169.9 M | Current Value 178.4 M | Quarterly Volatility 100.5 M |
Check Frequency Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Frequency Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.1 M, Interest Expense of 106.1 K or Other Operating Expenses of 51.6 M, as well as many indicators such as Price To Sales Ratio of 76.62, Dividend Yield of 0.0 or PTB Ratio of 0.46. Frequency financial statements analysis is a perfect complement when working with Frequency Therapeutics Valuation or Volatility modules.
Frequency | Total Stockholder Equity |
Latest Frequency Therapeutics' Total Stockholder Equity Growth Pattern
Below is the plot of the Total Stockholder Equity of Frequency Therapeutics over the last few years. It is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Frequency Therapeutics' Total Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Frequency Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Total Stockholder Equity | 10 Years Trend |
|
Total Stockholder Equity |
| Timeline |
Frequency Total Stockholder Equity Regression Statistics
| Arithmetic Mean | 18,767,303 | |
| Coefficient Of Variation | 535.55 | |
| Mean Deviation | 84,412,978 | |
| Median | (29,642,000) | |
| Standard Deviation | 100,507,976 | |
| Sample Variance | 10101.9T | |
| Range | 291.5M | |
| R-Value | 0.52 | |
| Mean Square Error | 7890.4T | |
| R-Squared | 0.27 | |
| Significance | 0.04 | |
| Slope | 11,779,314 | |
| Total Sum of Squares | 141425.9T |
Frequency Total Stockholder Equity History
About Frequency Therapeutics Financial Statements
Frequency Therapeutics investors utilize fundamental indicators, such as Total Stockholder Equity, to predict how Frequency Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Stockholder Equity | 169.9 M | 178.4 M |
Pair Trading with Frequency Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Frequency Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Frequency Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Frequency Stock
| 0.53 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.5 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.41 | NKTX | Nkarta Inc Buyout Trend | PairCorr |
| 0.36 | MNOV | MediciNova | PairCorr |
| 0.36 | PEPG | PepGen | PairCorr |
The ability to find closely correlated positions to Frequency Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Frequency Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Frequency Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Frequency Therapeutics to buy it.
The correlation of Frequency Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Frequency Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Frequency Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Frequency Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Frequency Therapeutics Correlation against competitors. To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Frequency Therapeutics. If investors know Frequency will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Frequency Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.43) | Return On Assets (0.35) | Return On Equity (0.75) |
The market value of Frequency Therapeutics is measured differently than its book value, which is the value of Frequency that is recorded on the company's balance sheet. Investors also form their own opinion of Frequency Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Frequency Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Frequency Therapeutics' market value can be influenced by many factors that don't directly affect Frequency Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Frequency Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Frequency Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Frequency Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.